American Century Companies’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
American Century Companies's MXCT Position: Q1 2026 in Review
American Century Companies sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 208,136 shares — an estimated $323K sold.
American Century Companies first reported a position in MXCT in Q1 2022 and held it in 16 quarters. The position peaked at $11.6M in Q1 2022. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- American Century Companies reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
- American Century Companies sold 208,136 MaxCyte shares in Q1 2026, an estimated $323K.
- American Century Companies first reported a position in MaxCyte in Q1 2022 and held it in 16 quarters.
- American Century Companies's MaxCyte position peaked at $11.6M in Q1 2022.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.